Institute of Cardiology, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.
Expert Rev Med Devices. 2011 Mar;8(2):235-55. doi: 10.1586/erd.10.80.
Based on the published results primarily from cohort studies, percutaneous lead extraction is now considered a safe procedure and indications for its use have broadened from device-related infections to less strict indications, such as recurrent isolated bacteremia, asymptomatic upper vein occlusion and malfunctioning/redundant leads. Almost 50% of electrophysiologists consider lead extraction in these latter situations. To broaden its implementation, further prospective evaluation against conservative approaches is still needed. Rather than only aiming at short-term results, this technique should be integrated into wide-ranging tailored long-term strategies to manage all of the different issues of implanted patients.
基于主要来自队列研究的已发表结果，经皮导线拔除术现在被认为是一种安全的操作，其适应证已经从与器械相关的感染扩大到不太严格的适应证，例如反复发作的孤立性菌血症、无症状的上腔静脉闭塞和故障/多余的导线。几乎 50%的电生理学家认为在这些情况下需要进行导线拔除术。为了扩大其应用，仍然需要针对保守方法进行进一步的前瞻性评估。这种技术不应仅着眼于短期结果，而应整合到广泛的定制长期策略中，以管理植入患者的所有不同问题。
